ibrutinib
Janssen,Abbvie
['ibru', 'nhl', 'dlbcl']
it was a busy few days . here is , &amp; with nhl29 iric poster. this study aimed to improve survival &amp;minimise side-effects with a novel therapy-ibrutinib-with chemotherapy in elderly patients newly diagnosed with dlbcl. 
Australia & New Zealand's only not-for-profit collaborative blood cancer research group